APA (7th ed.) Citation

Li, H., Bao, Y., Xu, A., Pan, X., Lu, J., Wu, H., . . . Jia, W. (2009). Serum Fibroblast Growth Factor 21 Is Associated with Adverse Lipid Profiles and γ-Glutamyltransferase But Not Insulin Sensitivity in Chinese Subjects. The journal of clinical endocrinology and metabolism, 94(6), 2151-2156. https://doi.org/10.1210/jc.2008-2331

Chicago Style (17th ed.) Citation

Li, Huating, Yuqian Bao, Aimin Xu, Xiaoping Pan, Junxi Lu, Haiya Wu, Huijuan Lu, Kunsan Xiang, and Weiping Jia. "Serum Fibroblast Growth Factor 21 Is Associated with Adverse Lipid Profiles and γ-Glutamyltransferase But Not Insulin Sensitivity in Chinese Subjects." The Journal of Clinical Endocrinology and Metabolism 94, no. 6 (2009): 2151-2156. https://doi.org/10.1210/jc.2008-2331.

MLA (9th ed.) Citation

Li, Huating, et al. "Serum Fibroblast Growth Factor 21 Is Associated with Adverse Lipid Profiles and γ-Glutamyltransferase But Not Insulin Sensitivity in Chinese Subjects." The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 6, 2009, pp. 2151-2156, https://doi.org/10.1210/jc.2008-2331.